FDA: Canagliflozin Linked to Amputations in Post-Marketing Trial
(MedPage Today) -- Monitoring committee suggests that CANVAS trial continue
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Canagliflozin | Health | International Medicine & Public Health | Invokana | Marketing